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Abstract Classical Menkes disease is a neurodegenerative
disorder caused by mutations in the copper-transporting
ATPase ATP7A gene which, when untreated, is usually fatal
in early childhood. A mild form of Menkes disease was
originally reported in 1981 and clinical progress of the
patient at 10 years described subsequently. The causative
mutation is c.4085C>T in exon 21, causing an alanine to
valine substitution in the highly conserved TM7 domain at
the C-terminal end of the Menkes protein. Here we report
his status at 34 years of age. Intellectual impairment is mild.
Ataxia has nearly resolved but motor retardation, dysarthria
and an extreme slow speech rate remain. In contrast to
patients with the occipital horn syndrome, there have been
no connective tissue complications of his mild Menkes
disease. He has been under long-term copper therapy for
more than 30 years and he continues to enjoy a good
quality of life.
Introduction
Menkes disease and the occipital horn syndrome are
disorders at either ends of a spectrum caused by mutations
in the copper-transporting ATPase ATP7A gene (OMIM
#300011) (Kaler et al. 1994; Tumer et al. 1997). Addition-
ally, specific mutations in ATP7A cause a distal motor
neuropathy that is clinically distinct (Kennerson et al.
2010). Infant males with classical Menkes syndrome
present in the first months of age with hypotonia, seizures
and failure to thrive. Other manifestations include auto-
nomic dysfunction, skin laxity, bladder diverticuli, pili torti
hair changes and characteristic facies. Untreated boys with
classical Menkes succumb in the first few years of life;
however, early treatment with parenteral copper-histidinate
may normalise the developmental outcomes in patients with
residual enzyme activity (Kaler et al. 2008; Christodoulou
et al. 1998). The occipital horn syndrome manifests with
prominent connective tissue abnormalities as well as
pathognomonic occipital exostoses; mild intellectual
impairment may be seen (Tsukahara et al. 1994).
Between these two disorders lies the mild form of
Menkes disease; the few described patients demonstrate
developmental delay, variable connective tissue manifes-
tations, pili torti and cerebellar ataxia but without seizures
or childhood death (Gerdes et al. 1988; Proud et al. 1996;
de Santos et al. 1984; Inagaki et al. 1988; Westman et al.
1988). Thus a clear distinction is drawn between classically
affected patients with longer survival (including those
treated with copper) and the mild Menkes patient.
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Our patient was originally described by Procopis et al. in
1981 and his progress at 10 years of age was reported
by David Danks (Procopis et al. 1981; Danks 1988). He
presented with cerebellar ataxia, pili torti and vascular
tortuosity. Follow-up demonstrated a predominantly motor
delay with extreme dysarthria requiring a communication
board until age 7. He commenced copper treatment at age
21 months and from 3 years has been on copper-histidinate
injections. Here we describe his clinical status at the age of
34 years.
Case Report
When previously reported his major problems were cerebel-
lar ataxia and dysarthria, both of which have improved,
though not normalised, over time. He now mobilises
independently without an ataxic gait and has a licence to
drive a car. His movement is however not normal and is
striking in the slowness with which he performs tasks. His
speech remains extremely slow and dysarthric although the
content is appropriate and his receptive understanding is not
limited.
Formal intelligence testing has not been performed, but he
is felt to function at the lowest end of normal. He underwent
normal schooling, albeit with assistance from teachers,
occupational therapists and speech pathologists. Long-term
employment has been difficult to achieve, although he has
worked periodically, predominantly due to his slowness of
speech rather than intellectual impairment. Seizures have not
occurred. Brain MRI was reported as normal at age 34.
Concurrent medical concerns have included nocturnal
enuresis until the age of 20 years, subclinical hypothyroidism
and frequent ear infections. Bladder ultrasound did not
demonstrate diverticuli. He has long-standing and stable mild
renal impairment with an estimated glomerular filtration rate
of 57 ml/min/1.73 m2 (>60 ml/min/1.73 m2). There is stable
microalbuminuria (urinary albumin:creatinine ratio 9.3
mg/mmol). Numerous investigations, but not including renal
biopsy, have failed to demonstrate a cause and it is likely due
to the damaging renal tubular effects of copper therapy
(Lenartowicz et al. 2010).
His facial appearance in infancy had some features of the
Menkes gestalt including pudgy cheeks and a carp-like
upper lip. In adulthood these features have dissipated and
he has a non-dysmorphic facial appearance. Pili torti was
documented in previous reports; although his hair grows at
a regular rate and he undergoes hair cuts every 6 weeks.
Likewise his facial hair is normal and he sports a goatee
beard (Fig. 1).
There was no orthostatic hypotension and his plasma
catecholamines were normal (adrenaline <0.3 nmol/l,
0.0–1.5; noradrenaline 1.6 nmol/l, 0.1–6.3). There was no
history of diarrhoea or abnormal sweating.
Connective tissue appears largely normal, without
extraordinary skin elasticity, varicose veins, joint hypermo-
bility or bony abnormalities such as scoliosis, radial head
deformity or dislocation. Lateral skull X-ray did not show
wormian bones or occipital horns. Arteriography at 21
months demonstrated vascular tortuosity; however, cerebral
magnetic resonance angiography at age 34 years demon-
strated only mild tortuosity of the cavernous portions of the
internal carotid arteries.
Copper-histidinate injections were maintained at 2.4 mg
every second day from his mid-teenage years until the age
of 32 years when they were changed to 3 mg every third
day. The decrease in injection frequency was at the patient’s
request as he found the injections increasingly difficult to
comply with. Blood levels were monitored regularly via his
local medical officer and most recently were slightly lower
than usual with copper 9.1 umol/l (12–22) and caerulo-
plasmin 0.18 g/l (0.25–0.80).
The diagnostic biochemical parameters in blood, tissue
and fibroblasts were reported in the original paper (Procopis
et al. 1981), and since that time the family mutation in the
ATP7A gene has been reported as c.4085C>T in exon 21,
causing an alanine to valine substitution in the highly
conserved TM7 domain at the C-terminal end of the Menkes
protein that abrogates its copper-induced translocation to the
plasma membrane (Ambrosini and Mercer 1999).
Discussion
In addition to our patient, a few other mild Menkes patients
have been described and from this a phenotypic picture of
variable intellectual impairment, ataxia and dysarthria,
bladder diverticuli and vascular tortuosity emerges. West-
man et al. described a 9 year old with near normal
psychomotor abilities, bladder diverticuli and vascular
tortuosity (Westman et al. 1988). Gerdes et al. described a
9 year old with borderline IQ and major problems of ataxia
and bladder diverticuli (Gerdes et al. 1988). A more
affected phenotype with prolonged survival comes from
the family in which the responsible gene was cloned. These
patients demonstrated various abnormalities across the
spectrum of Menkes disease and Occipital Horn syndrome,
with the 18 year old proband having mild intellectual
disability, pili torti, bladder diverticuli, seizures, intracere-
bral haemorrhage, cutis laxa, vascular tortuosity, ataxia,
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occipital horns, scoliosis, pectus and multiple joint dis-
locations (Kaler et al. 1994; Proud et al. 1996).
Our patient tolerated copper-histidinate injections for
more than 30 years and has demonstrated a slow improve-
ment in his dysarthria and ataxia. Additionally, cerebral
vascular tortuosity has lessened over time. Dysarthria and
motor retardation remain his biggest challenges. There have
not been long-term complications and in general he enjoys
a good quality of life.
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Fig. 1 Appearance of the patient at age 34
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